Cohance Lifesciences Limited (NSE:COHANCE)
India
· Delayed Price · Currency is INR 467.55
-25.75 (-5.22%)
Apr 29, 2026, 3:29 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 178.87 billion as of April 29, 2026. Its market cap has decreased by -35.42% in one year.
Market Cap
178.87B
Enterprise Value
180.74B
Revenue
10.79B
Ranking
n/a
PE Ratio
198.99
Stock Price
467.55
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 178.87B, an increase of 530,590.60%. That is a compound annual growth rate of 304.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alembic Pharmaceuticals | 150.29B |
| Eris Lifesciences | 188.17B |
| NATCO Pharma | 195.21B |
| Alivus Life Sciences | 128.25B |
| Piramal Pharma | 224.11B |
| Wockhardt | 233.58B |
| Strides Pharma Science | 101.26B |
| Gland Pharma | 292.53B |